Application of vitamin F in preparation of lipidosome and composite whitening agent lipidosome

By using vitamin F as a capsule modifier in whitening liposomes, combining the specific mass ratio of phospholipids and vitamin F, a composite whitening liposome with stability and permeability was prepared, and nanoliposomes were solved at high levels. The challenges in penetration and whitening agent application achieve effective release and deep penetration of whitening ingredients, improving the safety and whitening effect of the product.

CN119033601AInactive Publication Date: 2024-11-29GUANGZHOU KEYIMEI COSMETICS CO LTD

Patent Information

Application Number
CN202411229442.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-03
Publication Date
2024-11-29
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Nanoliposomes face size limitations, insufficient surface modification, stability problems and biological barrier penetration problems in achieving high permeability. The whitening agents 4-butyl resorcinol and ascorbic acid tetraisopalmitate are difficult to dissolve in water. It is prone to oxidation and discoloration and is irritating, which limits its application in whitening products.

Method used

Vitamin F is used as a capsule modification agent, and the mass ratio of phospholipids to vitamin F is 3 to 10:1 to 4 to prepare a complex whitening agent liposome, including 4-butyl resorcinol and ascorbic acid tetraisopalmitate , tocopherol acetate, lecithin and C2-C6 short-chain fatty alcohols, and microjet homogenization technology form liposomes with particle size of 50-500nm to improve permeability and stability.

Benefits of technology

Improve the stability and permeability of liposomes, ensure effective release and deep penetration of whitening ingredients, enhance the activity and permeability of skin cell membranes, reduce water loss and external invasion, and provide efficient and gentle whitening effects. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005025646620000141
    Figure BDA0005025646620000141
  • Figure BDA0005025646620000151
    Figure BDA0005025646620000151
  • Figure BDA0005025646620000161
    Figure BDA0005025646620000161
Patent Text Reader

Abstract

The invention provides application of vitamin F in preparation of lipidosome and composite whitening agent lipidosome, and particularly relates to the technical field of biomedical materials. The invention relates to application of vitamin F as a capsule modifier in preparation of lipidosome. The mass ratio of phospholipid to vitamin F in the lipidosome is (3-10): (1-4). Wherein the vitamin F is added to improve the activity and permeability of cell membranes, which is crucial to release and transdermal absorption of active components in the liposome. The antioxidant property of unsaturated fatty acid protects the skin from oxidative stress injury, enhances the flowability and stability of the liposome envelope, and reduces the structural change in the storage and use process, thereby enhancing the stability and functionality of the liposome. The vitamin F forms a protective layer on a skin cell membrane, and the protective layer not only can maintain the stability of the cell membrane, but also can block the contact between inflammatory factors and cancer factors and skin cells, so as to ensure the stability and safety of the cell membrane.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of biomedical materials, in particular to application of vitamin F in preparing liposomes and composite whitening agent liposomes. Background Art

[0002] As an advanced drug delivery system, nanoliposomes have attracted much attention due to their ability to mimic cell membrane structure, which enables them to naturally fuse with cell membranes, effectively improving the bioavailability and efficacy of drugs. However, despite their excellent performance in cell fusion, nanoliposomes still face many challenges in achieving high permeability, including size limitations, insufficient surface modification, stability issues, drug loading efficiency, and penetration of biological barriers.

[0003] In the field of cosmetics, the whitening agent 4-butylresorcinol is insoluble in water, easily oxidized and discolored, and irritating. The whitening agent ascorbyl tetraisopalmitate has a large molecular weight, is easily oxidized, and has low skin permeability. These characteristics limit their application in whitening products. 4-butylresorcinol or ascorbyl tetraisopalmitate is made into liposomes for encapsulation, which requires the liposomes to not only protect their stability but also ensure their effective release and penetration. The stability of liposomes is crucial for the activity of whitening agents. Environmental or physical factors may cause the capsule to rupture, resulting in the inactivation of active ingredients. In addition, the barrier formed by the stratum corneum of the skin has selective requirements on the permeability of liposomes. The design of highly permeable liposomes requires fine adjustment of surface modification and formulation to optimize the interaction with skin cells.

[0004] In view of this, the present invention is proposed. Summary of the invention

[0005] One of the purposes of the present invention is to provide a use of vitamin F as a capsule modifier in the preparation of liposomes to solve at least one of the above-mentioned technical problems in the prior art.

[0006] The second object of the present invention is to provide a composite whitening agent liposome.

[0007] The third object of the present invention is to provide a method for preparing composite whitening agent liposomes.

[0008] A fourth object of the present invention is to provide a cosmetic.

[0009] In order to achieve the above-mentioned purpose of the present invention, the following technical solutions are particularly adopted:

[0010] The first aspect of the present invention provides the use of vitamin F as a capsule modifier in the preparation of liposomes.

[0011] Furthermore, the mass ratio of the phospholipid in the liposome to the vitamin F is 3-10:1-4.

[0012] The second aspect of the present invention provides a composite whitening agent liposome, comprising a composite whitening agent, tocopherol acetate, a capsule modifier, lecithin, a C2-C6 short-chain fatty alcohol and deionized water.

[0013] Wherein, the composite whitening agent is 4-butylresorcinol and ascorbyl tetraisopalmitate.

[0014] The capsule modification agent is vitamin F.

[0015] Furthermore, the composite whitening agent liposome comprises, by mass percentage, 1-4% of 4-butylresorcinol, 5-12% of ascorbyl tetraisopalmitate, 5-12% of tocopherol acetate, 1-4% of capsule modifier, 3-10% of lecithin, 40-65% of C2-C6 short-chain fatty alcohol and 10-30% of deionized water.

[0016] Furthermore, the lecithin includes soybean lecithin and / or hydrogenated lecithin, preferably hydrogenated lecithin.

[0017] Preferably, the C2-C6 short-chain fatty alcohol includes at least one of ethanol, 1,2-propylene glycol, 1,3-propylene glycol, glycerol, butylene glycol, 1,2-butylene glycol, 1,4-butylene glycol and 2,3-butylene glycol, preferably glycerol.

[0018] Furthermore, the particle size of the composite whitening agent liposome is 50-500 nm, and the PDI is 0.01-0.5.

[0019] The third aspect of the present invention provides a method for preparing the composite whitening agent liposome, comprising the following steps:

[0020] A. Add the capsule modifier, the lecithin, the C2-C6 short-chain fatty alcohol and the deionized water into a container and mix them evenly to obtain a solution a;

[0021] B. Add the 4-butylresorcinol, the ascorbyl tetraisopalmitate and the tocopherol acetate into a container and mix them evenly to obtain a solution b;

[0022] C. Under stirring, adding the solution b into the solution a to obtain an emulsion; finally, homogenizing the emulsion to obtain the composite whitening agent liposome.

[0023] Furthermore, in step A, the mixing temperature is 50-80°C.

[0024] Preferably, in step C, the stirring speed is 500-800 rpm.

[0025] Preferably, in step C, the homogenization method is microfluidization homogenization.

[0026] Preferably, in step C, the pressure of the microfluidizer is 15000-25000 psi, the number of cycles is 1-5 times, and the discharge temperature is 20-40°C.

[0027] The fourth aspect of the present invention provides a cosmetic comprising the composite whitening agent liposomes described in the second aspect.

[0028] Furthermore, the pH of the cosmetic is 4.0 to 7.0, preferably 5.0 to 6.0.

[0029] Compared with the prior art, the present invention has at least the following beneficial effects:

[0030] The application provided by the present invention, wherein the addition of vitamin F improves the activity and permeability of the cell membrane, which is crucial for the release and transdermal absorption of active ingredients in liposomes. The antioxidant properties of unsaturated fatty acids help to neutralize free radicals, protect the skin from oxidative stress, and at the same time enhance the fluidity and stability of the liposome capsule, reduce structural changes during storage and use, thereby improving the stability and functionality of the liposome. The fat solubility of vitamin F enables it to naturally merge with the skin lipid barrier, and even at very low concentrations, it can effectively rebuild and strengthen this barrier, thereby protecting the skin from external aggression and reducing water loss. This protective effect is achieved through the protective layer formed by vitamin F on the skin cell membrane, which can not only maintain the stability of the cell membrane, but also block the contact between inflammatory factors and cancer factors and skin cells, ensuring the stability and safety of the cell membrane.

[0031] The composite whitening agent liposome provided by the present invention has a particle size of up to 50-500nm, a PDI of 0.01-0.5, a small specific surface area and a high uniformity; the four hydrophobic carbon chains of ascorbyl tetraisopalmitate can be combined with a polyol having a carbon number of 3, so that ascorbyl tetraisopalmitate can be firmly embedded in the phospholipid membrane; the phenolic hydroxyl group of 4-butylresorcinol and phosphatidylcholine may be combined in the form of a strong hydrogen bond, thereby making the phospholipid membrane of the liposome more stable. Therefore, the liposomes chimeric with ascorbyl tetraisopalmitate and 4-butylresorcinol have no significant fluctuations in particle size and PDI for 30 days at a temperature of 40-60°C. A high content of short-chain alcohol can regulate the deformation ability of the phospholipid membrane material, thereby enabling it to obtain a higher permeability, and the skin affinity and lipophilicity of phosphatidylcholine make it easier for the whitening active substance to be retained in the skin layer after penetrating into the stratum corneum, and it is not easy to enter the blood circulation through the dermis.

[0032] The preparation method of the composite whitening agent liposome provided by the present invention provides a stable lipid environment for the encapsulation of whitening ingredients by preparing solution a. This environment not only helps to maintain the activity of the whitening ingredients, but also enhances the compatibility and permeability of the liposome with the skin cell membrane through the effect of the capsule modifier. The whitening ingredients and the antioxidant ingredients are mixed to ensure the maximization of the whitening effect, and the addition of tocopherol acetate further improves the stability of the whole system. The solution a and the solution b are mixed to prepare an emulsion, forming the prototype of the composite whitening agent liposome, ensuring that the active ingredients are evenly distributed in the liposome, and laying a good foundation for subsequent homogenization. Finally, the composite whitening agent liposome with uniform particle size and good dispersibility is formed by homogenization. This step not only improves the physical stability of the liposome, but also enhances the permeability of the liposome by reducing the particle size, so that the whitening ingredients can more effectively penetrate the skin barrier and play a deep whitening effect. The preparation method provided by the present invention realizes the efficient encapsulation and stable release of the whitening ingredients, while improving the permeability and bioavailability of the liposome, and provides a new way for the efficient application of whitening agents.

[0033] The cosmetics provided by the present invention, in view of the advantages of the above-mentioned composite whitening agent liposomes, enable the prepared cosmetics to enhance the whitening effect, and also improve the safety, stability and sensory properties of the product, providing consumers with an efficient, gentle and excellent whitening skin care option. DETAILED DESCRIPTION

[0034] The embodiments of the present invention will be described in detail below in conjunction with the embodiments and examples, but those skilled in the art will understand that the following embodiments and examples are only used to illustrate the present invention and should not be considered to limit the scope of the present invention. Based on the embodiments in the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.

[0035] The first aspect of the present invention provides the use of vitamin F as a capsule modifier in the preparation of liposomes.

[0036] The application provided by the present invention, wherein the addition of vitamin F improves the activity and permeability of the cell membrane, which is crucial for the release and transdermal absorption of active ingredients in liposomes. The antioxidant properties of unsaturated fatty acids help to neutralize free radicals, protect the skin from oxidative stress, and at the same time enhance the fluidity and stability of the liposome capsule, reduce structural changes during storage and use, thereby improving the stability and functionality of the liposome. The fat solubility of vitamin F enables it to naturally merge with the skin lipid barrier, and even at very low concentrations, it can effectively rebuild and strengthen this barrier, thereby protecting the skin from external aggression and reducing water loss. This protective effect is achieved through the protective layer formed by vitamin F on the skin cell membrane, which can not only maintain the stability of the cell membrane, but also block the contact between inflammatory factors and cancer factors and skin cells, ensuring the stability and safety of the cell membrane.

[0037] The inventors have found that, compared with ordinary phosphatidylcholine lipid membranes, phosphatidylcholine lipid membranes combined with vitamin F can significantly enhance the binding of phospholipid membranes with skin cells and enhance the permeability of phospholipid membranes.

[0038] Vitamin F is a fat-soluble vitamin that mainly contains unsaturated fatty acids linoleic acid (ω-6) and linolenic acid (ω-3). As a nutrient in fat, even a small amount can rebuild the skin lipid barrier, protect the skin from damage and prevent water loss. Linolenic acid can maintain the stability of the skin cell membrane, form a protective film on the skin cell membrane, block the contact between inflammatory factors and cancer factors and skin cells, ensure the stability and safety of the cell membrane, and improve the activity and permeability of the cell membrane.

[0039] Furthermore, the mass ratio of the phospholipid in the liposome to the vitamin F is 3-10:1-4.

[0040] In liposomes, the mass ratio of phospholipids to vitamin F is in the range of 3-10:1-4, which ensures the stability of the liposome structure, because the right amount of phospholipids can form a stable lipid bilayer membrane, and the right amount of vitamin F helps to regulate the fluidity and permeability of the liposome, thereby maintaining the integrity of the liposome while enhancing its interaction with the skin cell membrane. At the same time, this mass ratio helps to improve the encapsulation efficiency of active ingredients, because the unsaturated fatty acids in vitamin F can increase the affinity of liposomes for active ingredients, thereby increasing the loading amount of active ingredients such as whitening agents, ensuring the concentration and effect of active ingredients in cosmetics.

[0041] In addition, the above ratio also helps to adjust the release characteristics of liposomes and achieve controlled release of whitening ingredients, so that the cosmetics can continuously release active ingredients during use, prolong the product's action time, and enhance the durability of the whitening effect. This mass ratio also helps to reduce the irritation of cosmetics, because vitamin F can form a protective layer on the surface of liposomes, reducing skin irritation that may be caused by active ingredients, making the cosmetics more gentle and suitable for all skin types.

[0042] Typically but not limiting, the mass ratio of phospholipids to vitamin F can be 3:1, 4:1, 5:1, 6:1, 7:1, 8:1, 9:1, 10:1, 3:4, 3:3, 3:2, 3:1 or 5:2, or any value within the range of 3 to 10:1 to 4.

[0043] The second aspect of the present invention provides a composite whitening agent liposome, comprising a composite whitening agent, tocopherol acetate, a capsule modifier, lecithin, a C2-C6 short-chain fatty alcohol and deionized water.

[0044] Wherein, the composite whitening agent is 4-butylresorcinol and ascorbyl tetraisopalmitate.

[0045] The capsule modification agent is vitamin F.

[0046] The composite whitening agent liposome provided by the present invention is compositely encapsulated with two highly efficient whitening ingredients, 4-butylresorcinol and ascorbyl tetraisopalmitate, and the two can significantly inhibit tyrosinase to achieve efficient whitening effect, while improving mixing stability and reducing irritation. In this process, the introduction of vitamin F as a capsule modifier plays a crucial role, and the unsaturated fatty acids linoleic acid and linolenic acid contained therein not only enhance the permeability of the liposome, but also form a protective film on the skin cell membrane, further improving the stability and activity of the cell membrane, thereby promoting the deep penetration of the whitening ingredients. In addition, the addition of tocopherol acetate provides additional antioxidant protection for the liposome, enhancing its stability during storage and use. Lecithin, as the basis of the liposome structure, works together with C2-C6 short-chain fatty alcohols to further optimize the fluidity and stability of the liposome, and using deionized water as a solvent ensures the uniformity and safety of the entire formula. The above raw materials cooperate with each other to improve the stability and efficient permeability of the liposome, ensuring that the whitening ingredients can play a role in the skin for a long time.

[0047] The composite whitening agent liposome provided by the present invention has a particle size of up to 50-500nm, a PDI of 0.01-0.5, a small specific surface area and a high uniformity; the four hydrophobic carbon chains of ascorbyl tetraisopalmitate can be combined with a polyol having a carbon number of 3, so that ascorbyl tetraisopalmitate can be firmly embedded in the phospholipid membrane; the phenolic hydroxyl group of 4-butylresorcinol and phosphatidylcholine may be combined in the form of a strong hydrogen bond, thereby making the phospholipid membrane of the liposome more stable. Therefore, the liposomes chimeric with ascorbyl tetraisopalmitate and 4-butylresorcinol have no significant fluctuations in particle size and PDI for 30 days at a temperature of 40-60°C. A high content of short-chain alcohol can regulate the deformation ability of the phospholipid membrane material, thereby enabling it to obtain a higher permeability. Further, the skin affinity and lipophilicity of phosphatidylcholine make it easier for the whitening active substance to be retained in the skin layer after penetrating into the stratum corneum, and it is not easy to enter the blood circulation through the dermis.

[0048] 4-Butylresorcinol is a derivative of resorcinol, which can effectively inhibit the activity of tyrosinase and the expression of tyrosinase-related protein 1, thereby effectively inhibiting the production of melanin. Studies have found that in the test of human tyrosinase, the IC50 value of 4-butylresorcinol was 21μmol / L, and the IC50 values ​​of 4-hexylresorcinol and 4-phenylethylresorcinol were 94μmol / L and 131μmol / L respectively; in the test of artificial skin model, 4-butylresorcinol was also the most effective of all tested substances, with a value of 13.5μmol / L. Similarly, in the artificial skin model experiment, the IC50 value of arbutin was greater than 5000μmol / L, and the IC50 value of kojic acid was greater than 400μmol / L, so it can be shown that 4-butylresorcinol has a strong whitening effect, which can significantly inhibit the synthesis and deposition of melanin, and inhibit the formation of chloasma and freckles.

[0049] Ascorbyl tetraisopalmitate is a fat-soluble vitamin C derivative that can inhibit the activity of tyrosinase and the production of melanin in cells to exert a whitening effect. In addition, it can reduce cell DNA damage caused by ultraviolet rays and prevent lipid peroxidation and skin aging. In the theory of skin permeability, it has good permeability only when the molecular weight is less than 600Da. Therefore, although ascorbyl tetraisopalmitate is fat-soluble, it is difficult to achieve the required whitening effect by its own permeability due to its large molecular weight. At the same time, ascorbyl tetraisopalmitate is a fat-soluble ingredient. When used in a non-emulsified system, a large amount of solubilizer is required. The complex water-based formula system will also cause it to oxidize and deteriorate, which will cause many difficulties in its application of the formula and product storage.

[0050] Furthermore, the composite whitening agent liposome comprises, by mass percentage, 1-4% of 4-butylresorcinol, 5-12% of ascorbyl tetraisopalmitate, 5-12% of tocopherol acetate, 1-4% of capsule modifier, 3-10% of lecithin, 40-65% of C2-C6 short-chain fatty alcohol and 10-30% of deionized water.

[0051] Typically but not limiting, the mass percentage composition of the composite whitening agent liposome can be specifically in the following ranges: the mass percentage of 4-butylresorcinol can be 1%, 2%, 3% or 4%, or any value in the range of 1% to 4%; the mass percentage of ascorbyl tetraisopalmitate can be 5%, 6%, 7%, 8%, 9%, 10%, 11% or 12%, or any value in the range of 5% to 12%; the mass percentage range of tocopherol acetate is the same as that of ascorbyl tetraisopalmitate; the mass percentage of the capsule modifier can be 1%, 2%, 3% or 4%; The mass percentage of lecithin can be 3%, 4%, 5%, 6%, 7%, 8%, 9% or 10%, or any value in the range of 3% to 10%; the mass percentage of C2-C6 short-chain fatty alcohol can be 40%, 45%, 50%, 55%, 60%, 65% or any proportion between these values, or any value in the range of 40% to 65%; the mass percentage of deionized water can be 10%, 15%, 20%, 25%, 30%, or any value in the range of 10% to 30%.

[0052] Furthermore, the lecithin includes soybean lecithin and / or hydrogenated lecithin, preferably hydrogenated lecithin.

[0053] Preferably, the C2-C6 short-chain fatty alcohol includes at least one of ethanol, 1,2-propylene glycol, 1,3-propylene glycol, glycerol, butylene glycol, 1,2-butylene glycol, 1,4-butylene glycol and 2,3-butylene glycol, preferably glycerol.

[0054] Furthermore, the particle size of the composite whitening agent liposome is 50-500 nm, and the PDI is 0.01-0.5.

[0055] Typically but not restrictively, the particle size of the composite whitening agent liposome can be 50nm, 60nm, 70nm, 80nm, 90nm, 100nm, 200nm, 300nm, 400nm or 500nm, or any value within the range of 50nm to 500nm.

[0056] Meanwhile, the polymer dispersibility index (PDI) is used as an indicator to measure the uniformity of the liposome particle size distribution, and its value can be 0.01, 0.02, 0.03, 0.04, 0.05, 0.1, 0.2, 0.3, 0.4 or 0.5, or any value within the range of 0.01 to 0.5. A low PDI value indicates that the liposome particle size distribution is very uniform, which helps to improve the stability of the product and the consistency of efficacy.

[0057] The third aspect of the present invention provides a method for preparing the composite whitening agent liposome, comprising the following steps:

[0058] A. Add the capsule modifier, the lecithin, the C2-C6 short-chain fatty alcohol and the deionized water into a container and mix them evenly to obtain a solution a;

[0059] B. Add the 4-butylresorcinol, the ascorbyl tetraisopalmitate and the tocopherol acetate into a container and mix them evenly to obtain a solution b;

[0060] C. Under stirring, adding the solution b into the solution a to obtain an emulsion; finally, homogenizing the emulsion to obtain the composite whitening agent liposome.

[0061] The preparation method of the composite whitening agent liposome provided by the present invention provides a stable lipid environment for the encapsulation of whitening ingredients by preparing solution a. This environment not only helps to maintain the activity of the whitening ingredients, but also enhances the compatibility and permeability of the liposome with the skin cell membrane through the effect of the capsule modifier. The whitening ingredients and the antioxidant ingredients are mixed to ensure the maximization of the whitening effect, and the addition of tocopherol acetate further improves the stability of the whole system. The solution a and the solution b are mixed to prepare an emulsion, forming the prototype of the composite whitening agent liposome, ensuring that the active ingredients are evenly distributed in the liposome, and laying a good foundation for subsequent homogenization. Finally, the composite whitening agent liposome with uniform particle size and good dispersibility is formed by homogenization. This step not only improves the physical stability of the liposome, but also enhances the permeability of the liposome by reducing the particle size, so that the whitening ingredients can more effectively penetrate the skin barrier and play a deep whitening effect. The preparation method provided by the present invention realizes the efficient encapsulation and stable release of the whitening ingredients, while improving the permeability and bioavailability of the liposome, and provides a new way for the efficient application of whitening agents.

[0062] Furthermore, in step A, the mixing temperature is 50-80°C.

[0063] Typically but not limiting, the mixing temperature in step A can be 50°C, 55°C, 60°C, 65°C, 70°C, 75°C or 80°C, or any value within the range of 50°C to 80°C.

[0064] Preferably, in step C, the stirring speed is 500-800 rpm.

[0065] Typically but not limiting, the stirring speed in step C can be 500 rpm, 550 rpm, 600 rpm, 650 rpm, 700 rpm, 750 rpm or 800 rpm, or any value within the range of 500 rpm to 800 rpm.

[0066] Preferably, in step C, the homogenization method is microfluidization homogenization.

[0067] Preferably, in step C, the pressure of the microfluidizer is 15000-25000 psi, the number of cycles is 1-5 times, and the discharge temperature is 20-40°C.

[0068] Typically but not limiting, the pressure of the microfluidizer can be 15000psi, 16000psi, 17000psi, 18000psi, 19000psi, 20000psi, 21000psi, 22000psi, 23000psi, 24000psi or 25000psi, or any value within the range of 15000psi to 25000psi. The number of cycles can be selected 1 time, 2 times, 3 times, 4 times or 5 times, or any number within the range of 1 to 5 times, according to the specific homogenization effect requirements, to ensure that the material achieves the desired particle size distribution and stability. The control of the discharge temperature is equally important, which can be 20°C, 25°C, 30°C, 35°C or 40°C, or any value within the range of 20°C to 40°C.

[0069] The fourth aspect of the present invention provides a cosmetic comprising the composite whitening agent liposomes described in the second aspect.

[0070] The cosmetics provided by the present invention, in view of the advantages of the above-mentioned composite whitening agent liposomes, enable the prepared cosmetics to enhance the whitening effect, and also improve the safety, stability and sensory properties of the product, providing consumers with an efficient, gentle and excellent whitening skin care option.

[0071] Furthermore, the pH of the cosmetic is 4.0 to 7.0, preferably 5.0 to 6.0.

[0072] Typically but not limiting, the pH range of the cosmetic may be 4.0, 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, 5.0, 5.1, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7, 5.8, 5.9, 6.0, 6.1, 6.2, 6.3, 6.4, 6.5, 6.6, 6.7, 6.8, 6.9 or 7.0, or any value within the range of 4.0 to 7.0.

[0073] Furthermore, when preparing the cosmetic, the temperature for adding the composite whitening agent liposome is below 40°C.

[0074] The results of the verification using the in vitro transdermal test guidelines specified in the European OECD / OCDE Guidelines for Chemical Testing show that the essence / emulsion using the composite whitening agent liposome of the present invention can significantly improve the skin retention rate of 4-butylresorcinol and ascorbyl tetraisopalmitate compared with commercially available products.

[0075] The present invention is further described below by specific examples and comparative examples, but it should be understood that these examples are only used for more detailed description and should not be understood as limiting the present invention in any form. The raw materials used in the examples and comparative examples of the present invention, if no specific conditions are specified, are carried out according to conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used without indicating the manufacturer are all conventional products that can be purchased commercially.

[0076] Example 1

[0077] This embodiment provides a composite whitening agent liposome, which is composed of the following components:

[0078] Glycerin 49.5%, deionized water 22.5%, hydrogenated lecithin 6%, ascorbyl tetraisopalmitate 10%, tocopheryl acetate 8%, vitamin F 2% and 4-butylresorcinol 2%.

[0079] The preparation method is as follows:

[0080] (1) Glycerol, hydrogenated lecithin, vitamin F, and deionized water were weighed in the mass ratio and placed in a container, and then stirred in a 70° C. water bath at 500 r / min until the solid matter was completely dissolved to obtain a solution a.

[0081] (2) Weigh ascorbyl tetraisopalmitate, tocopherol acetate, and 4-butylresorcinol according to the mass ratio, and stir manually until the solid powder is completely dissolved and transparent to obtain solution b.

[0082] (3) At 70°C, solution b was slowly poured into solution a, with the stirring speed maintained at 700 r / min for 8 min to obtain a uniform emulsion.

[0083] (4) The emulsion was homogenized by microfluidization, the homogenization pressure was controlled to be 20000 psi, the number of cycles was 3 times, and the discharge temperature was 35° C. to obtain composite whitening agent liposomes.

[0084] Example 2

[0085] This embodiment provides a composite whitening agent liposome, which is composed of the following components:

[0086] Glycerin 49.5%, deionized water 23.5%, hydrogenated lecithin 6%, ascorbyl tetraisopalmitate 10%, tocopheryl acetate 8%, vitamin F 1%, 4-butylresorcinol 2%.

[0087] The preparation method is the same as that of Example 1.

[0088] Example 3

[0089] This embodiment provides a composite whitening agent liposome, which is composed of the following components:

[0090] Glycerin 49.5%, deionized water 20.5%, hydrogenated lecithin 6%, ascorbyl tetraisopalmitate 10%, tocopheryl acetate 8%, vitamin F 4%, 4-butylresorcinol 2%.

[0091] The preparation method is the same as that of Example 1.

[0092] Example 4

[0093] This embodiment provides a composite whitening agent liposome, which is composed of the following components:

[0094] Glycerin 49.5%, deionized water 24%, hydrogenated lecithin 6%, ascorbyl tetraisopalmitate 10%, tocopheryl acetate 8%, vitamin F 0.5%, 4-butylresorcinol 2%.

[0095] The preparation method is the same as that of Example 1.

[0096] Example 5

[0097] This embodiment provides a composite whitening agent liposome, which is composed of the following components:

[0098] Glycerin 49.5%, deionized water 19.5%, hydrogenated lecithin 6%, ascorbyl tetraisopalmitate 10%, tocopheryl acetate 8%, vitamin F 5%, 4-butylresorcinol 2%.

[0099] The preparation method is the same as that of Example 1.

[0100] Example 6

[0101] This embodiment provides a composite whitening agent liposome, which is composed of the following components:

[0102] Glycerin 49.5%, deionized water 25.5%, hydrogenated lecithin 3%, ascorbyl tetraisopalmitate 10%, tocopheryl acetate 8%, vitamin F 2% and 4-butylresorcinol 2%.

[0103] The preparation method is the same as that of Example 1.

[0104] Example 7

[0105] This embodiment provides a composite whitening agent liposome, which is composed of the following components:

[0106] Glycerin 49.5%, deionized water 18.5%, hydrogenated lecithin 10%, ascorbyl tetraisopalmitate 10%, tocopheryl acetate 8%, vitamin F 2% and 4-butylresorcinol 2%.

[0107] The preparation method is the same as that of Example 1.

[0108] Example 8

[0109] This embodiment provides a composite whitening agent liposome, which is composed of the following components:

[0110] Glycerin 49.5%, deionized water 22.5%, soy lecithin 6%, ascorbyl tetraisopalmitate 10%, tocopheryl acetate 8%, vitamin F 2% and 4-butylresorcinol 2%.

[0111] The preparation method is the same as that of Example 1.

[0112] Comparative Example 1

[0113] This comparative example provides a composite whitening agent liposome, which is composed of the following components:

[0114] Glycerin 49.5%, deionized water 24.5%, hydrogenated lecithin 6%, ascorbyl tetraisopalmitate 10%, tocopheryl acetate 8% and 4-butylresorcinol 2%.

[0115] The preparation method is the same as that of Example 1, with the exception of adding vitamin F.

[0116] Comparative Example 2

[0117] This comparative example provides a composite whitening agent nanoemulsion, which is composed of the following components:

[0118] Glycerol 40%, deionized water 29%, Tween 80 5%, polyethylene glycol (30) dipolyhydroxystearate 6%, ascorbyl tetraisopalmitate 10%, tocopheryl acetate 8%, 4-butylresorcinol 2%.

[0119] The preparation method is as follows:

[0120] (1) Glycerol, Tween 80, polyethylene glycol (30) dipolyhydroxystearate, and deionized water were weighed in the mass ratio and placed in a container, and then stirred in a 60° C. water bath at 500 r / min until the solid matter was completely dissolved to obtain a solution a.

[0121] (2) Weigh ascorbyl tetraisopalmitate, tocopherol acetate, and 4-butylresorcinol according to the mass ratio, and stir manually until the solid powder is completely dissolved and transparent to obtain solution b.

[0122] (3) Slowly pour solution b into solution a at 70° C., maintain a stirring speed of 600 r / min, and a stirring time of 5 min. Then, use a high-speed shearing machine to shear at 12000 rpm for 10 min to obtain a preliminary emulsion.

[0123] (4) The preliminary emulsion was homogenized by microfluidization, the homogenization pressure was controlled to be 15000 psi, the number of cycles was 5 times, and the discharge temperature was 35° C. to obtain a composite whitening agent nanoemulsion.

[0124] Test Example 1

[0125] The liposomes or emulsions obtained in the examples and comparative examples were subjected to dynamic light scattering detection, and their average particle sizes and PDI after 24 hours and 30 days were measured, and their appearance after 30 days was observed. The results are recorded in Table 1.

[0126] Table 1

[0127]

[0128]

[0129] Test Example 2

[0130] The liposomes or emulsions obtained in the examples and comparative examples were diluted to compare their penetration abilities. The specific method was as follows:

[0131] Prepare 0.5% 4-butylresorcinol solution and 0.5% ascorbyl tetraisopalmitate solution solubilized by conventional method respectively:

[0132] ① 0.5% 4-butylresorcinol solution: weigh 0.5g 4-butylresorcinol (abbreviated as 577), add 2g Tween 80 for solubilization, 3g propylene glycol, 3g glycerol, 0.8g SIMULGEL FL, then add pure water to 100g, and then continue stirring at 60°C to obtain a uniform emulsion, which is a 0.5% 4-butylresorcinol solution.

[0133] ② Weigh 5 g of RH40, 10 g of propylene glycol, and 0.5 g of ascorbyl tetraisopalmitate (VCIP), stir in a 60°C water bath to obtain a clear and transparent liquid, then add 60°C pure water to 100 g under stirring, and continue stirring to obtain a clear and transparent 0.5% VCIP solution;

[0134] Prepare liposome diluent:

[0135] Weigh 5 g of the liposomes or emulsions prepared in the examples and comparative examples respectively into a beaker, then inject 95 g of pure water at room temperature and stir to obtain a uniform dispersion, which is the required 0.5% 4-butylresorcinol liposome dispersion and 0.5% ascorbyl tetraisopalmitate liposome dispersion.

[0136] Skin retention rate test: The skin permeation test is carried out according to the in vitro permeation test guidelines stipulated by the OECD / OCDE European OECD Chemical Testing Guidelines.

[0137] The specific operation method is:

[0138] 1. During the experiment, the washed Bama pig skin was cut into 2.5 cm × 2.5 cm size and fixed between the diffusion chamber and the receiving chamber of the franz cell diffusion cell. The receiving liquid of 4-butylresorcinol was a 1% sodium dodecyl sulfate (SDS) aqueous solution, and the receiving liquid of ascorbic acid tetraisopalmitate was a 10% PPG-13-decyltetradecyl alcohol polyether-24 aqueous solution.

[0139] 2. Add 0.02 g of the sample to be tested into the supply cell; place the assembled Franz diffusion cell into the transdermal diffusion instrument and set the experimental conditions as follows: temperature at 37 °C, stirring speed at 600 rpm, and transdermal time at 24 h.

[0140] 3. After the permeation, the pig skin was taken out from the diffusion cell, cut into pieces, and placed in a 2 mL tissue extraction tube. Ultrasonication was performed for 60 min, and the supernatant was filtered with a 0.22 μm organic filter membrane, and the contents of 4-butylresorcinol and ascorbyl tetraisopalmitate were determined by HPLC, i.e., the contents of 4-butylresorcinol and ascorbyl tetraisopalmitate retained in the skin.

[0141] The content data are recorded in Table 2.

[0142] Table 2

[0143]

[0144] Comparative analysis of Table 1 and Table 2 shows that the stability and skin retention of the sample of Example 1 are the best, indicating that the liposome nanoparticles prepared when the addition amount of vitamin F is 2% can maintain long-term stability and have a higher transdermal effect.

[0145] In Examples 3 and 5, the content of vitamin F is further increased, and the skin retention of 4-butylresorcinol (577) and ascorbyl tetraisopalmitate (VCIP) is gradually reduced. It may be that with the increase of vitamin F, the stability of the liposome is destroyed, resulting in the leakage of the internal composite whitening agent, thereby reducing the transdermal property; in Examples 2 and 4, the content of vitamin F is further reduced, and the skin retention of the composite whitening agent is gradually reduced. Therefore, it can be inferred that vitamin F can assist the composite whitening agent to penetrate into the stratum corneum of the skin to exert its effect and that the best addition amount in this system is 2%.

[0146] Comparative analysis of Example 1, Example 6 and Example 7 shows that if the content of hydrogenated lecithin in the system is too low, the viscosity of the entire system will be low, the emulsification effect will be poor, and slight stratification will occur during long-term observation, and the system will be uneven; if the content of hydrogenated lecithin is too high, the entire system will be viscous and have poor fluidity, causing inconvenience in use; therefore, after exploration, the hydrogenated lecithin content of the system is controlled at 6% to obtain nanoliposomes with better stability and fluidity.

[0147] It can be seen from Examples 1 and 8 that hydrogenated lecithin is more suitable as a basic raw material for preparing liposomes than soybean lecithin. Because soybean lecithin is a natural phospholipid, hydrogenated lecithin is the product of soybean lecithin hydrogenation, and the unsaturated chains of unsaturated fatty acids in hydrogenated lecithin disappear, so it has better stability, dispersibility and emulsification. The phase transition temperature of soybean lecithin is -20°C, and the phase transition temperature of hydrogenated lecithin after catalytic hydrogenation is 50°C. The higher phase transition temperature makes the liposomes prepared from hydrogenated lecithin have better stability and tolerance.

[0148] Comparative Example 2 is a simple liposome nanoemulsion without structural modification using vitamin F. Through the retention test, it can be found that the retention of the liposome modified with vitamin F is significantly improved, which may be because the unsaturated fatty acids in vitamin F change the fluidity of the phospholipid membrane, enhance the fusion of liposomes and cell membranes, and thus enhance the ability of active substances to enter cells.

[0149] The composite whitening agent can also be prepared into a nanoemulsion to form a more uniform system. By comparing Example 1 and Comparative Example 2, it can be seen that the particle size of the nanoliposome emulsion and the nanoemulsion is not much different, but from the perspective of long-term stability, the stability of the nanoliposome is much stronger than that of the nanoemulsion; the penetration effect of 4-butylresorcinol and ascorbic acid tetraisopalmitate in the composite whitening agent nanoemulsion prepared in Comparative Example 2 is equivalent to the penetration effect of ordinary 4-butylresorcinol essence and ascorbic acid tetraisopalmitate essence and does not have a promoting effect, while the nanoliposomes of Example 1 can significantly improve its penetration effect, indicating that the composite whitening agent nanoliposomes of Example 1 are a better solution.

[0150] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.

Claims

1. Application of vitamin F as a capsule modifier in the preparation of liposomes.

2. The use according to claim 1, characterized in that: The mass ratio of the phospholipid in the liposome to the vitamin F is 3-10:1-4.

3. A composite whitening agent liposome, characterized in that: It includes a composite whitening agent, tocopherol acetate, a capsule modifier, lecithin, C2-C6 short-chain fatty alcohol and deionized water; Wherein, the composite whitening agent is 4-butylresorcinol and ascorbyl tetraisopalmitate; The capsule modification agent is vitamin F.

4. The composite whitening agent liposome according to claim 3, characterized in that: Calculated by mass percentage, the invention comprises 1-4% of 4-butylresorcinol, 5-12% of ascorbic acid tetraisopalmitate, 5-12% of tocopherol acetate, 1-4% of capsule modifier, 3-10% of lecithin, 40-65% of C2-C6 short-chain fatty alcohol and 10-30% of deionized water.

5. The composite whitening agent liposome according to claim 3, characterized in that: The lecithin includes soybean lecithin and / or hydrogenated lecithin, preferably hydrogenated lecithin; Preferably, the C2-C6 short-chain fatty alcohol includes at least one of ethanol, 1,2-propylene glycol, 1,3-propylene glycol, glycerol, 1,2-butylene glycol, 1,4-butylene glycol and 2,3-butylene glycol, preferably glycerol.

6. The composite whitening agent liposome according to claim 3, characterized in that: The particle size is 50-500nm and the PDI is 0.01-0.

5.

7. A method for preparing the composite whitening agent liposome according to any one of claims 3 to 6, characterized in that: The following steps are involved: A. Add the capsule modifier, the lecithin, the C2-C6 short-chain fatty alcohol and the deionized water into a container and mix them evenly to obtain a solution a; B. Add the 4-butylresorcinol, the ascorbyl tetraisopalmitate and the tocopherol acetate into a container and mix them evenly to obtain a solution b; C. Under stirring, adding the solution b into the solution a to obtain an emulsion; finally, homogenizing the emulsion to obtain the composite whitening agent liposome.

8. The preparation method according to claim 7, characterized in that: In step A, the mixing temperature is 50 to 80° C.; Preferably, in step C, the stirring speed is 500-800 rpm; Preferably, in step C, the homogenization method is microfluidization; Preferably, in step C, the pressure of the microfluidizer is 15000-25000 psi, the number of cycles is 1-5 times, and the discharge temperature is 20-40°C.

9. A cosmetic, characterized in that: The invention comprises the composite whitening agent liposome according to any one of claims 3 to 6.

10. The cosmetic according to claim 9, characterized in that: The pH is 4.0 to 7.0, preferably 5.0 to 6.0.

Citation Information

Patent Citations

  • Skin whitening toning lotion containing lipidosome and preparation method thereof

    CN106214511A

  • 4-butylresorcinol liposome and preparation method thereof

    CN115836979A

  • Lipid solution composition and method for preparing NANO particle cosmetics having analogous structure and composition of human skin and promoting the transepidermal absorption of physiologically active substances using the same

    KR100654841B1

Cited By

  • Lipoic acid liposome as well as preparation method and application thereof

    CN121243036A